European Organisation for Research and Treatment of Cancer

From WikiMD's WELLNESSPEDIA

EORTC Logo

Pan-European cancer clinical research organization

European Organisation for Research and Treatment of Cancer (EORTC) is a pan-European, non-profit clinical cancer research organization established in 1962. It operates as an international association under Belgian law and is headquartered in Brussels, Belgium.

Mission and Objectives[edit]

The primary mission of EORTC is to improve the survival and quality of life of cancer patients through innovative and high-quality clinical trials and translational research. The organization develops and coordinates large-scale, multidisciplinary studies that evaluate new cancer treatments and therapeutic strategies, including:

  • Novel anticancer drugs
  • Combinations of currently approved therapies
  • Advanced radiotherapy and surgical oncology techniques
  • Personalized medicine approaches

Research Network and Infrastructure[edit]

EORTC operates a vast network of clinical cancer researchers and institutions across Europe and beyond. This includes:

  • Over 930 institutions in more than 30 countries
  • Thousands of collaborating investigators and research professionals
  • 220 full-time staff based at the headquarters in Brussels

The EORTC is uniquely positioned to conduct large, complex clinical trials across multiple countries, and it has particular expertise in trials involving:

Areas of Research[edit]

The EORTC covers a wide range of cancer types and research domains, including but not limited to:

  • Breast, lung, gastrointestinal, and genitourinary cancers
  • Hematological malignancies
  • Brain tumors
  • Soft tissue and bone sarcomas
  • Cancer survivorship and quality of life studies

It collaborates closely with pharmaceutical companies, academic institutions, cooperative groups, and regulatory bodies such as the European Medicines Agency (EMA).

Clinical Trial Excellence[edit]

EORTC trials are known for their scientific rigor, patient-centered design, and contribution to evidence-based oncology. The organization has played a key role in defining international standards of care in cancer therapy through landmark clinical trials that have influenced treatment guidelines and regulatory approvals.

External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=European_Organisation_for_Research_and_Treatment_of_Cancer&oldid=6540144"